Akdital S.A

CBSE:AKT Stock Report

Market Cap: د.م15.6b

Akdital Valuation

Is AKT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AKT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AKT (MAD1100) is trading above our estimate of fair value (MAD669.64)

Significantly Below Fair Value: AKT is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AKT?

Key metric: As AKT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AKT. This is calculated by dividing AKT's market cap by their current earnings.
What is AKT's PE Ratio?
PE Ratio70.6x
Earningsد.م220.64m
Market Capد.م15.58b

Price to Earnings Ratio vs Peers

How does AKT's PE Ratio compare to its peers?

The above table shows the PE ratio for AKT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average96.9x
HEAL Medikaloka Hermina
41.6x13.6%Rp23.2t
USPH U.S. Physical Therapy
94.1x30.8%US$1.3b
301293 Sanbo Hospital Management Group
78.3xn/aCN¥8.6b
002219 New Journey Health Technology GroupLTD
173.7xn/aCN¥8.7b
AKT Akdital
70.6x45.7%د.م15.6b

Price-To-Earnings vs Peers: AKT is good value based on its Price-To-Earnings Ratio (70.6x) compared to the peer average (97.2x).

Price to Earnings Ratio vs Industry

How does AKT's PE Ratio compare vs other companies in the Global Healthcare Industry?

12 CompaniesPrice / EarningsEstimated GrowthMarket Cap
AKT 70.6xIndustry Avg. 21.1xNo. of Companies69PE01632486480+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: AKT is expensive based on its Price-To-Earnings Ratio (70.6x) compared to the Global Healthcare industry average (20.9x).

Price to Earnings Ratio vs Fair Ratio

What is AKT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AKT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio70.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AKT's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AKT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentد.م1,100.00
د.م1,146.50
+4.2%
2.4%د.م1,174.00د.م1,119.00n/a2
Dec ’25د.م1,080.00
د.م1,146.50
+6.2%
2.4%د.م1,174.00د.م1,119.00n/a2
Nov ’25د.م1,030.00
د.م1,127.00
+9.4%
0.7%د.م1,135.00د.م1,119.00n/a2
Jun ’25د.م674.00
د.م448.50
-33.5%
19.1%د.م534.00د.م363.00n/a2
May ’25د.م720.20
د.م448.50
-37.7%
19.1%د.م534.00د.م363.00n/a2
Apr ’25د.م676.00
د.م448.50
-33.7%
19.1%د.م534.00د.م363.00n/a2
Mar ’25د.م690.00
د.م448.50
-35.0%
19.1%د.م534.00د.م363.00n/a2
Dec ’24د.م492.00
د.م448.50
-8.8%
19.1%د.م534.00د.م363.00د.م1,080.002
Nov ’24د.م505.00
د.م448.50
-11.2%
19.1%د.م534.00د.م363.00د.م1,030.002
Oct ’24د.م479.00
د.م448.50
-6.4%
19.1%د.م534.00د.م363.00د.م1,048.002

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 04:53
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Akdital S.A is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kais KriaaAlphaMena
Rim Ben Salah GharbiAlphaMena
Dounia FilaliBmce Capital Bourse